Cargando…
Molecular Mechanisms of Uterine Leiomyosarcomas: Involvement of Defect in LMP2 Expression
Patients with uterine leiomyosarcoma (LMS) typically present with vaginal bleeding, pain, and a pelvic mass. Typical presentations with hypercalcemia or eosinophilia have been reported. Radiographic evaluation with combined positron emission tomography/computed tomography may assist in the diagnosis...
Autores principales: | Hayashi, Takuma, Shimamura, Yuto, Saegusa, Taro, Horiuchi, Akiko, Kobayashi, Yukihiro, Hiraoka, Nobuyoshi, Kanai, Yae, Aburatani, Hiroyuki, Sano, Kenji, Konishi, Ikuo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733082/ https://www.ncbi.nlm.nih.gov/pubmed/19787091 |
Ejemplares similares
-
Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice
as an Animal Model of Spontaneous Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2011) -
Potential role of LMP2 as tumor-suppressor defines new targets for uterine
leiomyosarcoma therapy
por: Hayashi, Takuma, et al.
Publicado: (2011) -
Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma
por: Hayashi, Takuma, et al.
Publicado: (2011) -
Potential Biomarker for Human Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2014) -
Profiling of Target Molecules for Immunotherapy in Mesenchymal Tumors
por: Hayashi, Takuma, et al.
Publicado: (2019)